Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
transcatheter tricuspid valve repair (TTVR)
MedTech
At ESC 2025, researchers call for earlier, simpler TAVR
The new updates since 2021 are based on what the medical groups describe as “an exponential increase in medical knowledge" about heart valve disease.
Conor Hale
Aug 29, 2025 1:00pm
Abbott posts device sales gains after heart valve, CGM debuts
Jan 22, 2025 10:30am
Capstan collects $110M for robotic heart valve replacement
Dec 11, 2024 9:00am
Ten members of FDA's TriClip panel had financial ties to Abbott
Apr 10, 2024 10:25am
Abbott's TriClip receives FDA approval in tricuspid valve repair
Apr 2, 2024 11:28am
FDA panel supports Abbott's TriClip in tricuspid regurgitation
Feb 14, 2024 11:05am
